Boothbay Fund Management’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-81,270
Closed -$828K 1406
2025
Q1
$828K Buy
+81,270
New +$828K 0.02% 561